Mark S. Forman - Aug 12, 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Chief Medical Officer
Signature: /s/ Austin Rutherford, as Attorney-in-Fact
Stock symbol: VTYX
Transactions as of: Aug 12, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/13/2024, 04:48 PM
Previous filing: Mar 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (Right to Buy)	Award	$0	+350K		$0.00	350K	Aug 12, 2024	Common Stock	350K	$1.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the Option shall vest on the one year anniversary of the date of grant (the "Vesting Commencement Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.

Content

25% of the shares subject to the Option shall vest on the one year anniversary of the date of grant (the "Vesting Commencement Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.